Terapet SA

Terapet SA is a Swiss CERN spin-off founded in 2019 in Geneva by two CERN physicists, Dr. Christina Vallgren (CEO) and Dr. Marcus Palm (CTO), together with a world-leading radiation oncologist Prof. Raymond Miralbell (CSO). The company develops next-generation nuclear imaging systems for oncology in the fields of radiotherapy and nuclear medicine imaging. Terapet holds a strong IP position with 81 granted patents across six families, four registered trademarks, and positive Freedom-to-Operate status. Its platform technology underpins a growing product portfolio: Qual?scan®, a commercial solution for radiotherapy quality assurance; Nucl?scan®, a clinical-stage total-body PET scanner; and a third confidential pre-clinical product.